Management Considerations for Acute Coronary Syndromes in Chronic Kidney Disease.
Matthew I TomeyJanice Y ChyouPublished in: Current cardiology reports (2024)
Updated multisociety chest pain guidelines emphasize the diversity of clinical presentations of ACS, pertinent to recognition of ACS in patients with CKD. Evolving tools to predict and prevent acute kidney injury complicating invasive management of ACS serve to support improved access to and safety of percutaneous coronary intervention (PCI) in CKD patients, who remain at elevated risk. Growth in use of radial access, advances in PCI quality, incorporation of intravascular imaging, and new options and insights in pharmacotherapy contribute to an evolving calculus of ischemic and bleeding risk in ACS with bearing on management in CKD patients. Key opportunities to improve outcomes of ACS for patients with CKD center on avoiding underuse of beneficial medical and invasive therapies; enhancing safety of therapies by leveraging evidence-based strategies to prevent acute kidney injury; and devoting specific effort to investigation of ACS management in the context of CKD.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- chronic kidney disease
- antiplatelet therapy
- end stage renal disease
- acute kidney injury
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery bypass grafting
- coronary artery disease
- atrial fibrillation
- healthcare
- high resolution
- ejection fraction
- mass spectrometry
- heart failure
- coronary artery bypass
- insulin resistance
- patient reported outcomes
- newly diagnosed
- photodynamic therapy
- ischemia reperfusion injury